{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:06:54Z","timestamp":1788469614445,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,31]]},"DOI":"10.7759\/cureus.17606","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T15:29:31Z","timestamp":1630423771000},"source":"Crossref","is-referenced-by-count":7,"title":["Treatment of Acne Vulgaris by Topical Spironolactone Solution Compared With Clindamycin Solution"],"prefix":"10.7759","author":[{"given":"Adil","family":"Noaimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shatha R","family":"Al-Saadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Acne","author":"James WD","year":"2020","unstructured":"James WD, Elston DM, Treat JR, et al..  Acne. Andrews\u2019 Diseases of the Skin: Clinical Dermatology. Elsevier, Inc., Philadelphia; 2020. 13:231-51."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2013.11.005","article-title":"Acne as a chronic systemic disease","volume":"32","author":"Zouboulis CC","year":"2014","unstructured":"Zouboulis CC. Acne as a chronic systemic disease. Clin Dermatol. 2014, 32:389-96. 10.1016\/j.clindermatol.2013.11.005","journal-title":"Clin Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12298","article-title":"Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions","volume":"28","author":"Zouboulis CC","year":"2014","unstructured":"Zouboulis CC, Jourdan E, Picardo M. Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions. J Eur Acad Dermatol Venereol. 2014, 28:527-32. 10.1111\/jdv.12298","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-014-0099-z","article-title":"Recent advances in acne pathogenesis: implications for therapy","volume":"15","author":"Das S","year":"2014","unstructured":"Das S, Reynolds RV. Recent advances in acne pathogenesis: implications for therapy. Am J Clin Dermatol. 2014, 15:479-88. 10.1007\/s40257-014-0099-z","journal-title":"Am J Clin Dermatol"},{"key":"ref5","article-title":"Acne, rosacea and related disorders","author":"Habif TP","year":"2016","unstructured":"Habif TP. Acne, rosacea and related disorders. Clinical Dermatology, A Color Guide to Diagnosis and Therapy. Elsevier, Inc., Philadelphia; 2016. 218-62."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2016.1215430","article-title":"Spironolactone in the treatment of polycystic ovary syndrome","volume":"17","author":"Armanini D","year":"2016","unstructured":"Armanini D, Andrisani A, Bordin L, Sabbadin C. Spironolactone in the treatment of polycystic ovary syndrome. Expert Opin Pharmacother. 2016, 17:1713-5. 10.1080\/14656566.2016.1215430","journal-title":"Expert Opin Pharmacother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2010.488260","article-title":"Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial","volume":"23","author":"Afzali BM","year":"2012","unstructured":"Afzali BM, Yaghoobi E, Yaghoobi R, Bagherani N, Dabbagh MA. Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial. J Dermatolog Treat. 2012, 23:21-5. 10.3109\/09546634.2010.488260","journal-title":"J Dermatolog Treat"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/ejdv.ejdv_36_18","article-title":"Efficacy and safety of topical spironolactone 5% gel versus placebo in the treatment of acne vulgaris","volume":"39","author":"Attwa EM","year":"2019","unstructured":"Attwa EM, Al Shimaa MI, Abd El-Halim MF, Mahmoud HM. Efficacy and safety of topical spironolactone 5% gel versus placebo in the treatment of acne vulgaris. Egyptian J Dermatol Venerol. 2019, 39:89. 10.4103\/ejdv.ejdv_36_18","journal-title":"Egyptian J Dermatol Venerol"},{"key":"ref9","article-title":"Protein Synthesis Inhibitors","author":"Unger NR","year":"2015","unstructured":"Unger NR, Gauthier TP. Protein Synthesis Inhibitors. Lippincott\u2019s Illustrated Reviews: Pharmacology. Whalen K, Finkel R, Panavelil TA (ed): Wolters Kluwer, Alphen aan den Rijn; 2015. 499-512."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.618","article-title":"Management of acne: a report from a global alliance to improve outcomes in acne","volume":"49","author":"Gollnick H","year":"2003","unstructured":"Gollnick H, Cunliffe W, Berson D, et al.. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol. 2003, 49:S1-37. 10.1067\/mjd.2003.618","journal-title":"J Am Acad Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.51258","article-title":"Scoring systems in acne vulgaris","volume":"75","author":"Adityan B","year":"2009","unstructured":"Adityan B, Kumari R, Thappa DM. Scoring systems in acne vulgaris. Indian J Dermatol Venereol Leprol. 2009, 75:323-6. 10.4103\/0378-6323.51258","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2016.05.042","article-title":"Spironolactone loaded nanostructured lipid carrier gel for effective treatment of mild and moderate acne vulgaris: A randomized, double-blind, prospective trial","volume":"146","author":"Kelidari HR","year":"2016","unstructured":"Kelidari HR, Saeedi M, Hajheydari Z, et al.. Spironolactone loaded nanostructured lipid carrier gel for effective treatment of mild and moderate acne vulgaris: A randomized, double-blind, prospective trial. Colloids Surf B Biointerfaces. 2016, 146:47-53. 10.1016\/j.colsurfb.2016.05.042","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref13","article-title":"Acne vulgaris","author":"Zaenglein AL","year":"2018","unstructured":"Zaenglein AL, Thiboutot DM. Acne vulgaris. Dermatology. Bolognia JL, Schaffer JV, Cerroni L (ed): Elsevier, Philadelphia; 2018. 588-603."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.0465","article-title":"Efficacy and safety of topical Clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials","volume":"156","author":"Hebert A","year":"2020","unstructured":"Hebert A, Thiboutot D, Stein Gold L, Cartwright M, Gerloni M, Fragasso E, Mazzetti A. Efficacy and safety of topical Clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials. JAMA Dermatol. 2020, 156:621-30. 10.1001\/jamadermatol.2020.0465","journal-title":"JAMA Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.011106","article-title":"Emerging roles of the mineralocorticoid receptor in pathology: toward new paradigms in clinical pharmacology","volume":"68","author":"Jaisser F","year":"2016","unstructured":"Jaisser F, Farman N. Emerging roles of the mineralocorticoid receptor in pathology: toward new paradigms in clinical pharmacology. Pharmacol Rev. 2016, 68:49-75. 10.1124\/pr.115.011106","journal-title":"Pharmacol Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvy092","article-title":"The mineralocorticoid receptor as a modulator of innate immunity and atherosclerosis","volume":"114","author":"van der Heijden CD","year":"2018","unstructured":"van der Heijden CD, Deinum J, Joosten LA, Netea MG, Riksen NP. The mineralocorticoid receptor as a modulator of innate immunity and atherosclerosis. Cardiovasc Res. 2018, 114:944-53. 10.1093\/cvr\/cvy092","journal-title":"Cardiovasc Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/09546630410021702","article-title":"A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%","volume":"15","author":"Zhang JZ","year":"2004","unstructured":"Zhang JZ, Li LF, Tu YT, Zheng J. A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%. J Dermatolog Treat. 2004, 15:372-8. 10.1080\/09546630410021702","journal-title":"J Dermatolog Treat"},{"key":"ref18","article-title":"Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatment of acne vulgaris","volume":"15","author":"Alirezai M","year":"2005","unstructured":"Alirezai M, Gerlach B, Horvath A, Forsea D, Briantais P, Guyomar M. Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatment of acne vulgaris. Eur J Dermatol. 2005, 15:274-8.","journal-title":"Eur J Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.8.15.2625","article-title":"Topical clindamycin in the management of acne vulgaris","volume":"8","author":"Guay DR","year":"2007","unstructured":"Guay DR. Topical clindamycin in the management of acne vulgaris. Expert Opin Pharmacother. 2007, 8:2625-64. 10.1517\/14656566.8.15.2625","journal-title":"Expert Opin Pharmacother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/60000-treatment-of-acne-vulgaris-by-topical-spironolactone-solution-compared-with-clindamycin-solution","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:44Z","timestamp":1707506924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/60000-treatment-of-acne-vulgaris-by-topical-spironolactone-solution-compared-with-clindamycin-solution"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.17606","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,31]]}}}